跳至主要内容
临床试验/ACTRN12623000355673
ACTRN12623000355673
尚未招募
未知

Pilot and evaluation of a general practice led intervention to optimise National Bowel Cancer Screening Program participation.

niversity of Sydney0 个研究点目标入组 100 人2023年4月5日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
niversity of Sydney
入组人数
100
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年4月5日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • General Practices inclusion criteria:
  • Has at least two GPs (FTE) willing to participate in the trial
  • Nominated Practice Champion who is willing and able to liaise with the Daffodil Centre research team
  • Uses Medical Director or Best Practice software
  • Uses Pen CS, Polar or Primary Sense
  • Available over the trial period May 2023 – June 2023
  • Windows 10 or higher, i5/i7 16GB processing or willing to upgrade
  • Has over 1000 active patients and sees minimum of 35 adult patients per day
  • Adult patient inclusion criteria:
  • Inclusion criteria

排除标准

  • General Practice exclusion criteria:
  • Shares server with another practice
  • Uses paper\-based medical records
  • Does not share data with PHN
  • Adult patient exclusion criteria:
  • Exclusion criteria
  • Under 50 or over 74 years
  • Previous or current diagnosis of CRC
  • Previous or current diagnosis of inflammatory bowel disease – e.g., ulcerative colitis or Chron’s disease
  • Familial syndrome associated with increased risk of CRC: lynch syndrome, familial adenomatous polyposis (FAP), attenuated FAP (AFAP), MUTYH\-associated polyposis, polymerase proof\-reading associated polyposis (PPAP), NTHL1\-associated polyposis (NAP), Peutz\-Jeghers syndrome, Juvenile polyposis syndrome, Serrated polyposis syndrome, and Cowden syndrome

结局指标

主要结局

未指定

相似试验